Total Payments
$2,022
2024 Payments
$313.00
Companies
23
Transactions
134
Medicare Patients
971
Medicare Billing
$150,810
Payment Breakdown by Category
Food & Beverage$1,915 (94.7%)
Education$106.54 (5.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,915 | 130 | 94.7% |
| Education | $106.54 | 4 | 5.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $445.72 | 30 | $0 (2024) |
| Novo Nordisk Inc | $396.39 | 23 | $0 (2024) |
| ABBVIE INC. | $264.82 | 15 | $0 (2024) |
| PFIZER INC. | $260.65 | 26 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $81.44 | 4 | $0 (2019) |
| GlaxoSmithKline, LLC. | $76.37 | 5 | $0 (2024) |
| Purdue Pharma L.P. | $65.89 | 4 | $0 (2018) |
| Lilly USA, LLC | $62.67 | 4 | $0 (2023) |
| Daiichi Sankyo Inc. | $47.69 | 3 | $0 (2018) |
| Otsuka America Pharmaceutical, Inc. | $44.71 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $313.00 | 18 | Novo Nordisk Inc ($173.01) |
| 2023 | $350.87 | 20 | AbbVie Inc. ($138.19) |
| 2022 | $275.06 | 16 | AstraZeneca Pharmaceuticals LP ($163.24) |
| 2021 | $234.86 | 16 | PFIZER INC. ($85.16) |
| 2020 | $95.69 | 7 | Novo Nordisk Inc ($46.59) |
| 2019 | $75.96 | 5 | AstraZeneca Pharmaceuticals LP ($26.28) |
| 2018 | $234.00 | 15 | Novo Nordisk Inc ($56.51) |
| 2017 | $442.22 | 37 | PFIZER INC. ($122.98) |
All Payment Transactions
134 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Diabetes | ||||||
| 11/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: RESPIRATORY | ||||||
| 11/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.61 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: PSYCHIATRY | ||||||
| 10/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $25.10 | General |
| Category: Obesity | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: Respiratory | ||||||
| 09/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: Diabetes | ||||||
| 07/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: Diabetes | ||||||
| 07/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: Diabetes | ||||||
| 06/27/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Diabetes | ||||||
| 05/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.60 | General |
| Category: Diabetes | ||||||
| 04/11/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: NEUROSCIENCE | ||||||
| 03/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: Diabetes | ||||||
| 03/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: NEUROSCIENCE | ||||||
| 03/06/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: PSYCHIATRY | ||||||
| 03/05/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Diabetes | ||||||
| 11/15/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: Respiratory | ||||||
| 10/26/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: RESPIRATORY | ||||||
| 09/14/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: NEUROSCIENCE | ||||||
| 08/23/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: PSYCHIATRY | ||||||
| 08/10/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: NEUROSCIENCE | ||||||
| 06/21/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN, TRULANCE | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Gastroenterology | ||||||
| 06/08/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $33.75 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 241 | 548 | $99,656 | $40,433 |
| 2022 | 5 | 231 | 521 | $97,261 | $36,889 |
| 2021 | 5 | 224 | 539 | $104,572 | $39,027 |
| 2020 | 8 | 275 | 621 | $112,937 | $34,461 |
Total Patients
971
Total Services
2,229
Medicare Billing
$150,810
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 97 | 383 | $79,281 | $31,985 | 40.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 20 | $6,760 | $2,597 | 38.4% |
| 87636 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b | Office | 2023 | 12 | 16 | $4,564 | $2,236 | 49.0% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 35 | 35 | $2,100 | $1,110 | 52.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 20 | $3,000 | $1,092 | 36.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 35 | 35 | $1,470 | $1,010 | 68.7% |
| 92567 | Test to assess middle ear function | Office | 2023 | 23 | 27 | $2,025 | $254.73 | 12.6% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 12 | 12 | $456.00 | $148.20 | 32.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 107 | 380 | $78,660 | $29,579 | 37.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 22 | 38 | $12,844 | $4,733 | 36.9% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2022 | 41 | 41 | $2,460 | $1,227 | 49.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 41 | 41 | $1,722 | $1,115 | 64.7% |
| 92567 | Test to assess middle ear function | Office | 2022 | 20 | 21 | $1,575 | $235.08 | 14.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 115 | 414 | $85,698 | $32,165 | 37.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 27 | 38 | $12,844 | $4,659 | 36.3% |
| 90756 | Vaccine for influenza derived from cell cultures for injection into muscle, quadrivalent, antibiotic free, 0.5ml dosage | Office | 2021 | 36 | 36 | $2,160 | $1,021 | 47.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 11 | 16 | $2,400 | $630.89 | 26.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 35 | 35 | $1,470 | $550.90 | 37.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 131 | 453 | $93,771 | $29,618 | 31.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 21 | 31 | $10,478 | $2,489 | 23.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 16 | 23 | $3,450 | $629.25 | 18.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 37 | 37 | $1,554 | $588.67 | 37.9% |
| 90688 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 26 | 26 | $1,482 | $487.78 | 32.9% |
| 90756 | Vaccine for influenza for injection into muscle | Office | 2020 | 12 | 12 | $720.00 | $332.40 | 46.2% |
| 80305 | Testing for presence of drug | Office | 2020 | 19 | 20 | $760.00 | $250.50 | 33.0% |
About Dr. Benjamin Towe, MD
Dr. Benjamin Towe, MD is a Family Medicine healthcare provider based in Martinez, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1457335549.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Benjamin Towe, MD has received a total of $2,022 in payments from pharmaceutical and medical device companies, with $313.00 received in 2024. These payments were reported across 134 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($1,915).
As a Medicare-enrolled provider, Towe has provided services to 971 Medicare beneficiaries, totaling 2,229 services with total Medicare billing of $150,810. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Martinez, GA
- Active Since 12/01/2005
- Last Updated 11/24/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1457335549
Products in Payments
- BREZTRI (Drug) $260.43
- Ozempic (Drug) $209.29
- VRAYLAR (Drug) $186.10
- BEVESPI AEROSPHERE (Drug) $131.31
- JARDIANCE (Drug) $117.27
- VIAGRA (Drug) $89.19
- COLOGUARD DNA CAPTURE REAGENTS (Device) $85.16
- Victoza (Drug) $55.32
- Rybelsus (Drug) $46.57
- REXULTI (Drug) $44.71
- XIFAXAN (Drug) $42.49
- Kloxxado (Drug) $42.00
- CHANTIX (Drug) $40.65
- QUVIVIQ (Drug) $34.33
- LYRICA (Drug) $33.77
- UBRELVY (Drug) $33.75
- ANORO (Drug) $33.21
- FARXIGA (Drug) $31.23
- OXYCONTIN (Drug) $30.24
- TRELEGY ELLIPTA (Drug) $28.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Martinez
Brent Porteous, D.o, D.O
Family Medicine — Payments: $54,795
Family Medicine $54,795
Melodie Armstrong, Md, MD
Family Medicine — Payments: $40,949
Family Medicine $40,949
Melissa Hubiak
Family Medicine — Payments: $4,853
Family Medicine $4,853
Dr. Richard Carpenter, D.o., Ph.d, D.O., PH.D
Family Medicine — Payments: $3,320
Family Medicine $3,320
Craig Desoer
Family Medicine — Payments: $2,927
Family Medicine $2,927
Dr. Roger Brown, Md, MD
Family Medicine — Payments: $2,737
Family Medicine $2,737